On Thursday 3rd July 2025, Shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) recorded a significant 32.24 percent sharp fall following reports on $25M Stock Offering during the pre-market session, reaching a trading value of $1.45, This is versus the closing price of $2.14 seen from the prior trading day.
INOVIO Pharmaceuticals, Inc. (INO) announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock at an exercise price of $1.75 per share. The gross proceeds from the offering by INOVIO Pharmaceuticals, Inc. (INO) are expected to be approximately $25 million. The offering is anticipated to close on or about July 7, 2025.
